Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (472)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
22
2023
402
2.910
 Why?
Anus Neoplasms
10
2023
26
2.000
 Why?
Stroke
8
2024
520
1.830
 Why?
Acquired Immunodeficiency Syndrome
11
2022
53
1.510
 Why?
Prostatic Hyperplasia
10
2015
39
1.360
 Why?
Brain
10
2024
1350
1.320
 Why?
Parkinson Disease
2
2023
156
1.180
 Why?
Chlamydia Infections
8
2017
75
1.140
 Why?
Randomized Controlled Trials as Topic
8
2024
630
1.140
 Why?
Papillomavirus Infections
6
2022
177
1.080
 Why?
Mesenchymal Stem Cell Transplantation
2
2024
24
1.020
 Why?
Sarcoma, Kaposi
12
2022
77
0.990
 Why?
Chlamydia trachomatis
6
2017
29
0.960
 Why?
Lymphoma, AIDS-Related
10
2020
16
0.930
 Why?
Brain Ischemia
2
2023
162
0.850
 Why?
Plant Extracts
5
2013
200
0.830
 Why?
Humans
104
2026
53230
0.830
 Why?
Serenoa
5
2013
7
0.810
 Why?
Phytotherapy
3
2012
45
0.750
 Why?
Rural Population
4
2023
596
0.740
 Why?
Umbilical Cord
2
2020
36
0.740
 Why?
Lymphoma, Non-Hodgkin
6
2021
58
0.680
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
1043
0.670
 Why?
Middle Aged
50
2021
13419
0.660
 Why?
Research Design
5
2022
373
0.640
 Why?
Neonatal Abstinence Syndrome
3
2024
28
0.620
 Why?
Fetal Blood
2
2019
79
0.600
 Why?
Male
59
2024
27435
0.600
 Why?
Adult
50
2022
14534
0.600
 Why?
Inflammation
3
2021
652
0.580
 Why?
Rats
9
2024
3162
0.560
 Why?
Patient Participation
1
2018
72
0.550
 Why?
Vaginosis, Bacterial
2
2015
8
0.520
 Why?
Decision Making
1
2018
278
0.480
 Why?
Antineoplastic Agents
10
2023
1232
0.480
 Why?
Neoplasms
3
2023
1334
0.480
 Why?
Mammography
1
2016
99
0.480
 Why?
Stem Cells
3
2025
189
0.470
 Why?
Female
47
2024
28782
0.460
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
46
0.450
 Why?
Aged
28
2020
10429
0.440
 Why?
Infarction, Middle Cerebral Artery
3
2024
41
0.440
 Why?
Population Density
1
2014
17
0.440
 Why?
Pelvic Inflammatory Disease
2
2018
8
0.440
 Why?
AIDS-Related Opportunistic Infections
5
2016
38
0.430
 Why?
Stem Cell Transplantation
4
2025
191
0.430
 Why?
Animals
15
2026
13526
0.430
 Why?
Carcinoma in Situ
3
2013
72
0.420
 Why?
Cytokines
5
2023
627
0.410
 Why?
Uterine Cervicitis
1
2013
3
0.400
 Why?
Anti-Bacterial Agents
5
2020
830
0.400
 Why?
Urethritis
2
2012
5
0.390
 Why?
Hydrocephalus, Normal Pressure
1
2012
2
0.390
 Why?
Finasteride
4
2015
4
0.380
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
110
0.380
 Why?
Research Subjects
1
2013
53
0.370
 Why?
Guideline Adherence
1
2013
143
0.370
 Why?
Breast Neoplasms
3
2017
1222
0.370
 Why?
Rats, Sprague-Dawley
5
2024
1544
0.360
 Why?
Subarachnoid Hemorrhage
1
2012
57
0.360
 Why?
Patient Dropouts
1
2012
52
0.360
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
175
0.350
 Why?
Urologic Diseases
1
2011
9
0.350
 Why?
Homosexuality, Male
4
2022
54
0.350
 Why?
HIV-1
6
2020
60
0.340
 Why?
Analgesics, Opioid
4
2024
622
0.330
 Why?
Lung Neoplasms
2
2013
645
0.330
 Why?
Disease Models, Animal
5
2024
1517
0.320
 Why?
Mitochondria
3
2026
446
0.320
 Why?
Young Adult
17
2019
4511
0.320
 Why?
Papillomaviridae
3
2019
104
0.320
 Why?
United States
10
2023
5409
0.310
 Why?
Patient Selection
1
2011
273
0.300
 Why?
Quality of Life
6
2024
902
0.300
 Why?
HIV Seropositivity
3
2021
28
0.300
 Why?
Lymphedema
2
2022
48
0.300
 Why?
Lower Urinary Tract Symptoms
3
2013
7
0.300
 Why?
Intestinal Mucosa
2
2021
229
0.300
 Why?
Asthma
2
2024
319
0.290
 Why?
Polymorphism, Single Nucleotide
3
2017
505
0.280
 Why?
Gonorrhea
2
2020
9
0.280
 Why?
Uterine Cervical Neoplasms
2
2022
301
0.270
 Why?
Azithromycin
4
2020
25
0.270
 Why?
Anal Canal
4
2023
27
0.260
 Why?
Prospective Studies
12
2022
2411
0.260
 Why?
Th1 Cells
2
2017
50
0.260
 Why?
Risk Factors
8
2022
4017
0.260
 Why?
Vascular Endothelial Growth Factor A
4
2017
189
0.250
 Why?
Huntington Disease
1
2026
24
0.240
 Why?
Mycoplasma genitalium
2
2018
2
0.240
 Why?
Doxazosin
3
2015
3
0.240
 Why?
Mycoplasma Infections
2
2018
7
0.240
 Why?
Prevalence
7
2021
1034
0.240
 Why?
Treatment Outcome
16
2020
5595
0.230
 Why?
Doxycycline
3
2015
33
0.230
 Why?
Cyclophosphamide
9
2021
178
0.230
 Why?
Cancer Vaccines
1
2006
79
0.230
 Why?
Anti-Infective Agents
2
2020
107
0.230
 Why?
Vincristine
8
2021
89
0.220
 Why?
Adolescent
13
2022
6907
0.220
 Why?
Multicenter Studies as Topic
4
2024
114
0.220
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
610
0.220
 Why?
Circadian Rhythm
1
2025
91
0.220
 Why?
Air Filters
1
2024
1
0.210
 Why?
Double-Blind Method
4
2013
729
0.210
 Why?
CD4 Lymphocyte Count
7
2020
33
0.210
 Why?
Bronchiolitis
1
2024
28
0.210
 Why?
Air Pollution, Indoor
1
2024
27
0.210
 Why?
5-alpha Reductase Inhibitors
2
2015
4
0.210
 Why?
Hyperbaric Oxygenation
1
2023
15
0.200
 Why?
Neoplasm Staging
5
2022
774
0.200
 Why?
Substantia Nigra
1
2023
14
0.200
 Why?
Cell Differentiation
3
2025
681
0.200
 Why?
alpha-Synuclein
1
2023
11
0.200
 Why?
Doxorubicin
8
2021
247
0.200
 Why?
Cisplatin
3
2022
282
0.200
 Why?
Transplantation Conditioning
2
2018
96
0.200
 Why?
Tumor Necrosis Factor-alpha
2
2017
392
0.200
 Why?
Informatics
1
2023
9
0.200
 Why?
Herpesvirus 8, Human
5
2020
98
0.190
 Why?
Prednisone
7
2021
101
0.190
 Why?
Follow-Up Studies
8
2019
2318
0.190
 Why?
Astrocytes
1
2024
139
0.190
 Why?
Cross-Sectional Studies
3
2021
1723
0.190
 Why?
Brachytherapy
1
2022
51
0.190
 Why?
Neuroprotective Agents
2
2020
101
0.190
 Why?
Watchful Waiting
1
2022
29
0.190
 Why?
Medical Records
1
2022
85
0.190
 Why?
Oxidative Phosphorylation
1
2022
48
0.190
 Why?
Absorptiometry, Photon
1
2003
160
0.180
 Why?
Feasibility Studies
2
2021
411
0.180
 Why?
Substance Withdrawal Syndrome
1
2023
168
0.180
 Why?
Brain Injuries
1
2023
160
0.180
 Why?
Vitamin D Deficiency
1
2022
46
0.180
 Why?
Vaccines
1
2022
49
0.180
 Why?
Viral Load
6
2020
83
0.180
 Why?
Genome-Wide Association Study
3
2018
184
0.180
 Why?
Child
7
2024
7379
0.180
 Why?
Case-Control Studies
3
2014
1212
0.180
 Why?
Precancerous Conditions
1
2022
87
0.180
 Why?
Clinical Trials as Topic
5
2020
466
0.180
 Why?
Lymphocyte Activation
3
2017
163
0.180
 Why?
Mouth Diseases
1
2021
5
0.180
 Why?
Thymus Gland
1
2021
39
0.170
 Why?
Mass Screening
2
2015
362
0.170
 Why?
Vaccination
3
2022
310
0.170
 Why?
Pluripotent Stem Cells
1
2021
8
0.170
 Why?
Progestins
1
2020
10
0.170
 Why?
T-Lymphocyte Subsets
2
2017
39
0.170
 Why?
Physical Conditioning, Animal
1
2021
67
0.170
 Why?
Drug Therapy, Combination
5
2015
405
0.170
 Why?
Vagina
2
2018
45
0.170
 Why?
Etoposide
5
2021
71
0.170
 Why?
Primary Health Care
2
2022
404
0.170
 Why?
Spleen
1
2021
166
0.170
 Why?
Papillomavirus Vaccines
2
2013
74
0.160
 Why?
Enzyme Inhibitors
2
2016
371
0.160
 Why?
Anti-HIV Agents
3
2020
47
0.160
 Why?
Cross-Over Studies
1
2021
241
0.160
 Why?
Genes, myc
1
2020
39
0.160
 Why?
Gene Frequency
2
2017
97
0.160
 Why?
Overweight
1
2022
232
0.160
 Why?
Transplantation, Autologous
3
2018
488
0.160
 Why?
Aged, 80 and over
5
2013
3494
0.150
 Why?
Nervous System Diseases
1
2020
93
0.150
 Why?
Dihydroxyphenylalanine
1
2019
5
0.150
 Why?
Dopaminergic Neurons
1
2019
19
0.150
 Why?
Ablation Techniques
1
2019
19
0.150
 Why?
Infant, Newborn
5
2024
2913
0.150
 Why?
Genitalia, Male
1
2019
16
0.150
 Why?
Altruism
1
2018
12
0.150
 Why?
Sodium, Dietary
1
2019
24
0.140
 Why?
Central Nervous System Diseases
1
2019
28
0.140
 Why?
Mouth
1
2019
36
0.140
 Why?
Asymptomatic Infections
1
2018
7
0.140
 Why?
Dopamine
1
2019
167
0.140
 Why?
Antiviral Agents
2
2013
179
0.140
 Why?
Sexually Transmitted Diseases
1
2018
37
0.140
 Why?
Encephalitis
1
2018
40
0.140
 Why?
Hyperthermia, Induced
1
2019
114
0.140
 Why?
Chlamydia
1
2017
8
0.140
 Why?
Mucous Membrane
1
2017
32
0.130
 Why?
Energy Metabolism
1
2020
324
0.130
 Why?
Regeneration
1
2018
83
0.130
 Why?
Blood Cells
1
2017
37
0.130
 Why?
Biopsy
2
2022
600
0.130
 Why?
Pilot Projects
3
2019
726
0.130
 Why?
Exosomes
1
2018
58
0.130
 Why?
Genetic Predisposition to Disease
2
2018
533
0.130
 Why?
Protein Kinase Inhibitors
2
2023
233
0.130
 Why?
DNA, Circular
1
2017
17
0.130
 Why?
Clostridium Infections
1
2018
56
0.130
 Why?
Antibodies, Bacterial
1
2017
29
0.130
 Why?
Clonal Evolution
1
2017
59
0.130
 Why?
Immunoglobulins
1
2017
76
0.130
 Why?
Immunoglobulin G
1
2017
192
0.120
 Why?
Enzyme-Linked Immunosorbent Assay
2
2017
233
0.120
 Why?
Sentinel Lymph Node Biopsy
1
2017
119
0.120
 Why?
Anus Diseases
1
2016
2
0.120
 Why?
Lymph Node Excision
1
2017
132
0.120
 Why?
Mannitol
1
2016
14
0.120
 Why?
Telemedicine
1
2022
512
0.120
 Why?
Guidelines as Topic
1
2016
111
0.120
 Why?
Thiazoles
1
2016
52
0.120
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
7
0.120
 Why?
Diagnostic Self Evaluation
1
2015
13
0.120
 Why?
Blood-Brain Barrier
1
2016
51
0.120
 Why?
Dose-Response Relationship, Drug
4
2013
1367
0.120
 Why?
CD4-Positive T-Lymphocytes
1
2017
166
0.120
 Why?
T-Lymphocytes
1
2017
321
0.120
 Why?
Educational Status
1
2016
229
0.120
 Why?
Tinidazole
2
2012
2
0.120
 Why?
Imidazoles
1
2016
114
0.110
 Why?
Time Factors
6
2023
2991
0.110
 Why?
Burkitt Lymphoma
1
2015
27
0.110
 Why?
Lymph Nodes
1
2017
252
0.110
 Why?
Drug Administration Schedule
5
2020
370
0.110
 Why?
Menarche
1
2014
7
0.110
 Why?
Chromosomes, Human, Pair 2
1
2014
25
0.110
 Why?
Data Collection
3
2023
288
0.110
 Why?
Stomatitis
1
2014
19
0.110
 Why?
Immunophenotyping
2
2017
118
0.110
 Why?
Obesity
3
2022
1204
0.110
 Why?
Disease-Free Survival
5
2016
466
0.110
 Why?
Benzamides
1
2013
52
0.100
 Why?
Hypogonadism
1
2013
13
0.100
 Why?
Carcinoma, Squamous Cell
1
2016
332
0.100
 Why?
Incidence
4
2018
1085
0.100
 Why?
Urban Population
1
2014
162
0.100
 Why?
SEER Program
1
2013
106
0.100
 Why?
Health Surveys
1
2014
248
0.100
 Why?
Regenerative Medicine
2
2025
12
0.100
 Why?
Organophosphonates
1
2013
6
0.100
 Why?
Perineum
1
2013
26
0.100
 Why?
DNA, Viral
3
2020
136
0.100
 Why?
Testosterone
1
2013
142
0.100
 Why?
Placebos
1
2013
80
0.100
 Why?
Heart Failure
1
2019
531
0.100
 Why?
Cytosine
1
2013
30
0.100
 Why?
Adrenergic alpha-Antagonists
2
2009
27
0.100
 Why?
Piperazines
1
2013
125
0.100
 Why?
tau Proteins
1
2012
25
0.100
 Why?
Prostate
2
2015
118
0.100
 Why?
Trichomonas Infections
1
2012
2
0.090
 Why?
Trichomonas vaginalis
1
2012
2
0.090
 Why?
HIV
3
2023
26
0.090
 Why?
Transforming Growth Factor beta1
1
2012
61
0.090
 Why?
Pyrimidines
1
2013
205
0.090
 Why?
Vulvar Neoplasms
1
2013
61
0.090
 Why?
Sleep
2
2024
195
0.090
 Why?
Urination Disorders
1
2011
23
0.090
 Why?
Androgen Antagonists
1
2011
13
0.090
 Why?
Medicare
1
2013
280
0.090
 Why?
Comorbidity
1
2013
638
0.090
 Why?
Sirolimus
1
2012
72
0.090
 Why?
Antibiotics, Antineoplastic
1
2012
83
0.090
 Why?
CD8-Positive T-Lymphocytes
2
2017
145
0.090
 Why?
Kenya
2
2022
11
0.090
 Why?
Quinazolinones
1
2011
7
0.080
 Why?
Human papillomavirus 16
2
2013
44
0.080
 Why?
Practice Guidelines as Topic
1
2013
502
0.080
 Why?
Arkansas
1
2016
2068
0.080
 Why?
Social Class
1
2011
97
0.080
 Why?
Multivariate Analysis
1
2012
598
0.080
 Why?
Chronic Disease
1
2012
580
0.080
 Why?
Prognosis
5
2017
2118
0.080
 Why?
Piperidines
1
2011
98
0.080
 Why?
Plant Bark
1
2009
4
0.080
 Why?
Multiple Myeloma
2
2014
3082
0.080
 Why?
Valproic Acid
1
2009
35
0.080
 Why?
Ki-67 Antigen
1
2009
57
0.080
 Why?
Socioeconomic Factors
1
2012
623
0.080
 Why?
Colorectal Neoplasms
1
2013
302
0.070
 Why?
Logistic Models
1
2012
947
0.070
 Why?
India
2
2021
59
0.070
 Why?
Fruit
1
2009
129
0.070
 Why?
Tetracyclines
2
2006
9
0.070
 Why?
Neoplasm Recurrence, Local
1
2012
647
0.070
 Why?
Survival Analysis
3
2017
659
0.070
 Why?
Antiretroviral Therapy, Highly Active
3
2015
32
0.070
 Why?
Adaptive Immunity
2
2017
32
0.070
 Why?
Glioblastoma
1
2009
101
0.070
 Why?
Chemoradiotherapy
2
2019
50
0.070
 Why?
Sexual Partners
2
2018
45
0.060
 Why?
Disease Progression
4
2013
880
0.060
 Why?
Stress, Psychological
1
2009
282
0.060
 Why?
Regression Analysis
2
2018
391
0.060
 Why?
Chaperonins
1
2006
3
0.060
 Why?
Chaperonin 60
1
2006
6
0.060
 Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.060
 Why?
Lymphocyte Count
1
2006
20
0.060
 Why?
Papillomavirus E7 Proteins
1
2006
30
0.060
 Why?
Immunohistochemistry
3
2017
975
0.060
 Why?
Viral Vaccines
1
2006
16
0.060
 Why?
HIV Protease Inhibitors
1
2006
3
0.060
 Why?
Sexual Behavior
2
2018
142
0.060
 Why?
Coculture Techniques
1
2026
146
0.060
 Why?
Interferon-alpha
1
2006
53
0.060
 Why?
Nephrosis, Lipoid
1
2005
7
0.060
 Why?
Infant
2
2024
3805
0.060
 Why?
Arterioles
1
2005
32
0.060
 Why?
Body Mass Index
2
2022
717
0.060
 Why?
Recombinant Fusion Proteins
1
2006
175
0.060
 Why?
Severity of Illness Index
2
2023
1049
0.060
 Why?
Circadian Clocks
1
2025
3
0.060
 Why?
Matrix Metalloproteinase 9
3
2017
88
0.060
 Why?
Brain Neoplasms
1
2009
319
0.060
 Why?
Administration, Oral
4
2013
456
0.060
 Why?
Administration, Intranasal
1
2024
30
0.060
 Why?
Anti-Retroviral Agents
2
2019
18
0.050
 Why?
Phenotype
2
2017
803
0.050
 Why?
Neutropenia
2
2020
113
0.050
 Why?
Genotype
2
2017
563
0.050
 Why?
Confidence Intervals
2
2015
158
0.050
 Why?
Dust
1
2024
24
0.050
 Why?
Particulate Matter
1
2024
66
0.050
 Why?
Carbon
1
2024
60
0.050
 Why?
Cytochrome P-450 CYP3A
1
2023
78
0.050
 Why?
Neurons
1
2026
394
0.050
 Why?
Femur Neck
1
2003
6
0.050
 Why?
Africa South of the Sahara
1
2022
6
0.050
 Why?
Bacterial Proteins
1
2006
347
0.050
 Why?
Hip
1
2003
24
0.050
 Why?
Oligomycins
1
2022
8
0.050
 Why?
Rotenone
1
2022
13
0.050
 Why?
Narcotics
1
2023
108
0.050
 Why?
Galactose
1
2022
29
0.050
 Why?
Quality Control
1
2003
98
0.050
 Why?
Sample Size
1
2022
50
0.050
 Why?
Eating
1
2023
159
0.050
 Why?
Breast Feeding
1
2024
203
0.050
 Why?
Femur
1
2003
133
0.050
 Why?
Vitamins
1
2022
64
0.050
 Why?
Spine
1
2003
87
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
9
0.050
 Why?
Mice
2
2026
5982
0.050
 Why?
Glycolysis
1
2022
76
0.050
 Why?
Tetracycline
1
2002
24
0.050
 Why?
Radiotherapy Dosage
1
2022
249
0.050
 Why?
Vitamin D
1
2022
91
0.040
 Why?
Sodium
1
2022
89
0.040
 Why?
Tretinoin
1
2002
53
0.040
 Why?
Leg
1
2022
123
0.040
 Why?
Fibroblast Growth Factor 2
2
2017
35
0.040
 Why?
Antibodies, Monoclonal
1
2005
477
0.040
 Why?
Museums
1
2021
2
0.040
 Why?
Alprostadil
1
2021
9
0.040
 Why?
Ischemia
1
2022
158
0.040
 Why?
Progesterone
1
2020
57
0.040
 Why?
Oxygen
1
2023
338
0.040
 Why?
Kidney
1
2005
715
0.040
 Why?
Zimbabwe
1
2020
3
0.040
 Why?
Length of Stay
1
2024
684
0.040
 Why?
Receptors, Progesterone
1
2020
68
0.040
 Why?
Malawi
1
2020
15
0.040
 Why?
Wharton Jelly
1
2020
2
0.040
 Why?
Uganda
1
2020
38
0.040
 Why?
Software
1
2003
280
0.040
 Why?
Cell Shape
1
2020
21
0.040
 Why?
Spinal Cord Injuries
1
2020
56
0.040
 Why?
Herpesvirus 4, Human
1
2020
44
0.040
 Why?
Neisseria gonorrhoeae
1
2020
4
0.040
 Why?
Body Composition
1
2003
355
0.040
 Why?
Glucose
1
2022
361
0.040
 Why?
Herpesviridae Infections
1
2020
57
0.040
 Why?
Ceftriaxone
1
2020
24
0.040
 Why?
Histone Deacetylase Inhibitors
1
2020
60
0.040
 Why?
B-Lymphocytes
1
2021
178
0.040
 Why?
Thrombocytopenia
1
2020
89
0.040
 Why?
Drug Resistance, Bacterial
1
2020
79
0.040
 Why?
Interleukin-6
2
2016
272
0.040
 Why?
Remission Induction
2
2012
221
0.040
 Why?
Proctoscopy
1
2019
2
0.040
 Why?
Kaplan-Meier Estimate
1
2020
487
0.040
 Why?
Microbial Sensitivity Tests
1
2020
274
0.040
 Why?
Radiation-Sensitizing Agents
1
2019
50
0.040
 Why?
Forelimb
1
2018
4
0.040
 Why?
Cell Survival
1
2020
600
0.040
 Why?
Green Fluorescent Proteins
1
2018
85
0.040
 Why?
Rats, Inbred F344
1
2018
194
0.030
 Why?
Statistics, Nonparametric
2
2013
198
0.030
 Why?
Models, Animal
1
2019
233
0.030
 Why?
Receptors, Chemokine
1
2017
12
0.030
 Why?
Cluster Analysis
1
2018
237
0.030
 Why?
Coinfection
1
2018
41
0.030
 Why?
Pandemics
1
2022
595
0.030
 Why?
Bone Marrow
1
2019
359
0.030
 Why?
Neurodegenerative Diseases
1
2019
81
0.030
 Why?
Postural Balance
1
2018
59
0.030
 Why?
Neurogenesis
1
2017
29
0.030
 Why?
Cell Separation
1
2017
76
0.030
 Why?
Muscle Strength
1
2018
132
0.030
 Why?
Cytological Techniques
1
2017
13
0.030
 Why?
Interleukin-2
1
2017
69
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Axilla
1
2017
92
0.030
 Why?
Angiopoietin-2
1
2017
17
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
48
0.030
 Why?
Staining and Labeling
1
2017
94
0.030
 Why?
Fluorouracil
1
2016
59
0.030
 Why?
Gene Rearrangement
1
2017
76
0.030
 Why?
Biopsy, Needle
1
2017
181
0.030
 Why?
Odds Ratio
1
2018
567
0.030
 Why?
Membrane Glycoproteins
1
2017
238
0.030
 Why?
Interferon-gamma
1
2017
174
0.030
 Why?
Mastectomy
1
2017
147
0.030
 Why?
Cord Blood Stem Cell Transplantation
1
2016
9
0.030
 Why?
Directly Observed Therapy
1
2015
5
0.030
 Why?
Urine
1
2015
26
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
16
0.030
 Why?
Vaginal Smears
1
2015
28
0.030
 Why?
Neovascularization, Pathologic
1
2017
158
0.030
 Why?
RNA, Viral
2
2009
123
0.030
 Why?
Flow Cytometry
1
2017
400
0.030
 Why?
Neoadjuvant Therapy
1
2017
124
0.030
 Why?
Treatment Failure
1
2015
119
0.030
 Why?
Prisons
1
2015
40
0.030
 Why?
Ifosfamide
1
2015
9
0.030
 Why?
Cytarabine
1
2015
44
0.030
 Why?
Magnetic Resonance Imaging
1
2022
1583
0.030
 Why?
Methotrexate
1
2015
78
0.030
 Why?
Induction Chemotherapy
1
2014
65
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
58
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
19
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
34
0.030
 Why?
Cohort Studies
1
2018
1557
0.030
 Why?
Melphalan
1
2014
180
0.030
 Why?
Depression
1
2019
621
0.030
 Why?
Statistics as Topic
1
2013
89
0.020
 Why?
Cancer Care Facilities
1
2013
20
0.020
 Why?
Gene Expression Regulation
1
2017
1003
0.020
 Why?
Time
1
2013
28
0.020
 Why?
Administration, Cutaneous
1
2013
53
0.020
 Why?
Infusions, Intravenous
1
2013
211
0.020
 Why?
Specialization
1
2013
48
0.020
 Why?
Demography
1
2013
91
0.020
 Why?
Molecular Targeted Therapy
1
2013
138
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
62
0.020
 Why?
Combined Modality Therapy
1
2014
640
0.020
 Why?
Antitrichomonal Agents
1
2012
1
0.020
 Why?
Reference Values
1
2013
311
0.020
 Why?
Risk Assessment
1
2017
1368
0.020
 Why?
Polyethylene Glycols
1
2012
95
0.020
 Why?
Medical Oncology
1
2013
97
0.020
 Why?
Antigens, Viral
1
2012
44
0.020
 Why?
Administration, Topical
1
2011
62
0.020
 Why?
Single-Blind Method
1
2011
120
0.020
 Why?
Neoplasm Proteins
1
2013
330
0.020
 Why?
Organ Size
1
2011
226
0.020
 Why?
Sex Factors
1
2013
747
0.020
 Why?
Antibodies, Viral
1
2010
109
0.020
 Why?
Survival Rate
1
2012
949
0.020
 Why?
Retrospective Studies
1
2022
6819
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
325
0.020
 Why?
Mutation
1
2013
1337
0.020
 Why?
Busulfan
1
2008
18
0.020
 Why?
Psychometrics
1
2009
244
0.020
 Why?
Ultrasonography
1
2008
426
0.020
 Why?
Maximum Tolerated Dose
1
2006
42
0.010
 Why?
Injections, Subcutaneous
1
2006
55
0.010
 Why?
Hypertension, Renal
1
2005
21
0.010
 Why?
Cell Proliferation
1
2009
1031
0.010
 Why?
Fatigue
1
2006
127
0.010
 Why?
Recombinant Proteins
1
2006
489
0.010
 Why?
Receptors, Interleukin-6
1
2002
22
0.010
 Why?
Endothelial Growth Factors
1
2002
11
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
15
0.010
 Why?
Lymphokines
1
2002
20
0.010
 Why?
Drug Tolerance
1
2002
60
0.010
 Why?
Safety
1
2002
78
0.010
 Why?
Child, Preschool
1
2005
4162
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (472) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (29) people
_
Same Department Expand Description
Search Department